Ceftriaxone Kabi

:Broad spectrum antibiotic
:for severe gram-negative hospital acquired infections
:Reliable efficacy and good tolerance
:Convenient once-daily dosing schedule
:Product manufactured by Fresenius Kabi in Europe

Ten clear glass vials in a carton box

:indicated for the treatment of following infections caused by micro-organisms susceptible to ceftriaxone:

• Abdominal infection (Peritonitis)
• Lower respiratory tract infection
• ENT infection
• Kidneys and urinary tract infection
• Infection of genital organs
• Bone and Joint infection
• Skin and soft tissue infection
• Septicemia
• Meningitis
• Neutropenic fever
• Perioperative prophylaxis in patient with increased risk of infection

:In adults and adolescents aged (over 12 years) of ≥ 50kg body weight is 1 – 2 g of Ceftriaxone administered once a day (every 24 hours). In serious infections or infections caused by moderately sensitive microorganisms, the dose can be raised up to 4 g administered once a day intravenously.

:Children (15 days -12 years) aged of < 50 kg , 20 – 80 mg/kg bw intravenously once daily (24 hour intervals). In severe infections, the daily dose of 80 mg/kg bw must not be exceeded, except in meningitis.

:Newborn infants (age 0 – 14 days) , 20 -5- mg/kg bw intravenously once daily (24 hour intervals). Even in severe infections, the daily dose of 50 mg/kg bw must not be exceeded.

: Elderly , the dosage recommendations for elderly patient is the same as for adults